J7505 — Muromonab-cd3, parenteral, 5 mg
J7505 is a HCPCS Level II code for muromonab-cd3, parenteral, 5 mg. It belongs to the Drugs Administered Other Than Oral Method section. It was terminated on December 31, 2025 and is not valid on new claims.
This code has been terminated
CMS terminated J7505 on December 31, 2025. It stays in the file as history — a claim you are auditing from before that date may legitimately carry it — but it must not appear on a new claim. The adjacent codes below are the usual place to look for its replacement.
Medicare coverage: Special coverage instructions apply
There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.
From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.
The CMS record for J7505
- Long descriptor
- Muromonab-cd3, parenteral, 5 mg
- Short descriptor
- Monoclonal antibodies
- Added
- January 1, 1988
- Terminated
- December 31, 2025
- BETOS
- O1E
- Pricing indicator
- 51 — Other
The official wording. This is what the code means.
CMS's 28-character form, which is what shows up on a remittance advice.
When CMS introduced the code.
When CMS retired it.
Berenson-Eggers Type of Service — CMS's own analytic grouping.
Drugs.
Codes adjacent to J7505
HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If J7505 is not quite right, the correct code is very often within a few positions of it.
- J7356Injection, foscarbidopa 0.25 mg/foslevodopa 5 mg
- J7401Mometasone furoate sinus implant, 10 microgramsterminated
- J7402Mometasone furoate sinus implant, (sinuva), 10 micrograms
- J7500Azathioprine, oral, 50 mg
- J7501Azathioprine, parenteral, 100 mg
- J7502Cyclosporine, oral, 100 mg
- J7503Tacrolimus, extended release, (envarsus xr), oral, 0.25 mg
- J7504Lymphocyte immune globulin, antithymocyte globulin, equine, parenteral, 250 mg
- J7506Prednisone, oral, per 5 mgterminated
- J7507Tacrolimus, immediate release, oral, 1 mg
- J7508Tacrolimus, extended release, (astagraf xl), oral, 0.1 mg
- J7509Methylprednisolone oral, per 4 mg
- J7510Prednisolone oral, per 5 mg
- J7511Lymphocyte immune globulin, antithymocyte globulin, rabbit, parenteral, 25 mg
- J7512Prednisone, immediate release or delayed release, oral, 1 mg
- J7513Daclizumab, parenteral, 25 mgterminated
Questions about J7505
What is HCPCS code J7505?
J7505 is a HCPCS Level II code for muromonab-cd3, parenteral, 5 mg. It sits in the Drugs Administered Other Than Oral Method section.
Does Medicare cover J7505?
The CMS HCPCS file marks J7505 as "Special coverage instructions apply". There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.
Is J7505 still valid?
No. J7505 was terminated on December 31, 2025 and should not be used on new claims.